Classification
Product TypeIngredient
Product FormUnmixed vitamin (bulk ingredient for formulation)
Industry PositionNutraceutical and food-fortification ingredient
Market
Vitamin E (HS 2936.28) in New Zealand is primarily supplied through imports and used as an ingredient for dietary supplements and for formulation of supplemented/fortified foods. UN Comtrade data (via World Bank WITS) reports New Zealand imports of vitamin E and its derivatives (unmixed) at USD 6.603 million in 2024, indicating an import-dependent market. Regulatory handling depends on product categorisation: dietary supplements are regulated under the Dietary Supplements Regulations 1985 administered by Medsafe, while supplemented foods are regulated by the Ministry for Primary Industries (MPI). The main market-access focus is correct categorisation, compliant labelling/claims (including restrictions on therapeutic claims), and timely customs entry lodgement for clearance.
Market RoleNet importer (import-dependent market) for vitamin E (HS 2936.28)
Domestic RoleDownstream formulation market (dietary supplements and supplemented foods) reliant on imported vitamin E inputs
SeasonalityNo meaningful seasonality; availability is driven by global production and shipping lead times rather than New Zealand harvest cycles.
Specification
Physical Attributes- When marketed as a dietary supplement in New Zealand, vitamin E products are typically presented in controlled dosage forms (for example capsules, tablets, powders, or liquids), and must be labelled as required by the Dietary Supplements Regulations 1985.
Compositional Metrics- Potency/quantity per recommended daily dose is a core specification and labelling element for vitamin E dietary supplement products in New Zealand.
Grades- Dietary-supplement compliant presentation and labelling (Dietary Supplements Regulations 1985) versus supplemented-food compliance pathway (MPI import process for supplemented foods).
Packaging- Retail packs must carry required label elements for dietary supplements (including the words “dietary supplement” and a consumer information panel) under the Dietary Supplements Regulations 1985.
Supply Chain
Value Chain- Overseas vitamin E manufacturer (HS 2936.28) → New Zealand importer/distributor → downstream formulator/packer (dietary supplement or food manufacturer) → wholesale distribution → retail/online sales
Temperature- Oxidation-sensitive ingredient: protect from heat and direct light during storage and distribution; align handling to supplier stability guidance.
Atmosphere Control- Minimise oxygen exposure for bulk ingredient handling and after opening (oxidation control) where relevant to supplier specifications.
Shelf Life- Shelf-life performance is formulation- and packaging-dependent; stock rotation and container integrity are critical for quality retention.
Freight IntensityLow
Transport ModeSea
Risks
Regulatory Compliance HighMisclassification (dietary supplement vs supplemented food vs medicine) and non-compliant claims/labels can block market access in New Zealand; the Dietary Supplements Regulations 1985 restrict therapeutic claims and set labelling requirements, and Medsafe administers these rules for dietary supplements.Confirm product categorisation using Medsafe/MPI guidance before shipment; run a label-and-claims compliance review against the Dietary Supplements Regulations 1985 (and FSANZ Standard 1.2.7 if marketed as a food making nutrition/health claims).
Documentation Gap MediumCustoms clearance delays can occur if the importer does not lodge the required electronic import entry in time, increasing storage/demurrage and lead-time disruption risk for New Zealand supply.Use a Customs broker/freight forwarder and pre-lodge import documentation to align with New Zealand Customs entry requirements.
Food Safety MediumAs there is no pre-approval for dietary supplements in New Zealand, the sponsor bears responsibility for acceptable quality and safety; insufficient supplier quality assurance or inadequate batch documentation can create enforcement, withdrawal, or reputational risk.Require supplier batch CoA and quality documentation; implement incoming inspection and stability/retention sample procedures aligned to the sponsor’s risk assessment.
Logistics LowNew Zealand’s distance from major manufacturing hubs increases exposure to shipping schedule variability; delays can disrupt replenishment cycles even for low freight-intensity, high-value ingredients.Hold safety stock sized to ocean lead times and use dual sourcing where feasible for critical SKUs.
Standards- GMP evidence and batch-level quality documentation (risk-based expectation driven by sponsor responsibility for quality and safety under the New Zealand dietary supplements framework)
FAQ
What HS code is typically used for unmixed vitamin E and its derivatives?Vitamin E and its derivatives (unmixed) are classified under HS 2936.28 (HS 6-digit code 293628).
Who regulates vitamin E dietary supplements in New Zealand?Dietary supplements in New Zealand are regulated under the Dietary Supplements Regulations 1985, which are administered by Medsafe. MPI regulates supplemented foods, so the regulator depends on how the product is categorised.
What is the biggest compliance risk when marketing vitamin E products in New Zealand?The biggest risk is getting the product categorisation, labelling, and claims wrong. The Dietary Supplements Regulations 1985 restrict therapeutic claims for dietary supplements and set labelling requirements, and non-compliance can lead to enforcement action or blocked sales.